Loading stock data…
Guardian Pharmacy Services (GRDN)
$40.44-1.87 (-4.42%)
Market ClosedLast close Jun 29
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Guardian Pharmacy Services, Inc. in the Healthcare sector is trading at $40.44 with a market capitalization of $2.8B. Wall Street consensus targets $47.00 (6 analysts), implying a +16.2% move over the next 12 months. The stock is currently near its 52-week high of $44.00, remaining 23.7% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +16.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $336.60M↓ | $397.62M↑ | $377.43M↑ | $344.33M↑ | $329.31M |
| Gross Profit | $76.31M↓ | $85.50M↑ | $74.72M↑ | $68.15M↑ | $64.35M |
| Operating Income | $17.68M↓ | $30.76M↑ | $16.35M↑ | $12.58M↓ | $13.01M |
| Net Income | $13.29M↓ | $20.92M↑ | $9.82M↑ | $9.03M↓ | $9.45M |
Peer Comparison
JNJUNHPFE
Fundamentals
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.77B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.02%
Volume
Today's trading volume
364,383
Recent News
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD and MAMA for gains.
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AMNEAL PHARMACEUTICALS, INC. (AMRX) Hits Fresh High: Is There Still Room to Run?
Amneal (AMRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?
Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Statutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings Are
Investors were underwhelmed by the solid earnings posted by Guardian Pharmacy Services, Inc. ( NYSE:GRDN ) recently...